COMMUNIQUÉS West-GlobeNewswire

Stryker reports first quarter 2025 operating results
01/05/2025
Portage, Michigan, May 01, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the first quarter of 2025: First Quarter Results Reported net sales increased 11.9% to $5.9 billion Organic net sales [...]
Streamline Health® Announces New eValuator™ Contract with Ohio-Based Health System
01/05/2025
1,100 bed health system selects eValutor’s pre-bill code audit technology to improve coding accuracy ATLANTA, May 01, 2025 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of [...]
Adaptive Biotechnologies Reports First Quarter 2025 Financial Results
01/05/2025
SEATTLE, May 01, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive [...]
Zevra Therapeutics to Participate in the Citizens Life Science Conference
01/05/2025
CELEBRATION, Fla., May 01, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage rare disease therapeutics company, today announced that members of Zevra’s [...]
Kura Oncology Reports First Quarter 2025 Financial Results
01/05/2025
– NDA submitted in 1Q 2025 for ziftomenib for the treatment of adult patients with relapsed or refractory AML with an NPM1 mutation – – Data from Phase 1b/2 registration-directed trial of ziftomenib selected for oral [...]
NextCure Provides Business Update and Reports First Quarter 2025 Financial Results
01/05/2025
Dosing cohort 3 of the Phase 1 trial of LNCB74 (B7-H4 ADC) in multiple cancers and plan to initiate backfill cohorts in the second half of 2025 Plan to provide a proof of concept data readout in the first half of 2026 [...]
Genelux Corporation to Participate in a Fireside Chat at the Citizens Life Sciences Conference
01/05/2025
WESTLAKE VILLAGE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick , President, CEO and Chairman of the [...]
89bio Reports First Quarter 2025 Financial Results and Corporate Updates
01/05/2025
– Topline histology data from ENLIGHTEN-Fibrosis and ENLIGHTEN-Cirrhosis Phase 3 trials are expected in 1H 2027 and in 2028, respectively; each trial is designed to support accelerated approval to treat patients with [...]
Ardelyx Reports First Quarter 2025 Financial Results and Provides Business Update
01/05/2025
Company reports $74.1 million in Q1 total revenue, reflecting 61% growth year-over-year IBSRELA net product sales revenue of $44.4 million; XPHOZAH net product sales revenue of $23.4 million Company ends Q1 with $214.0 [...]
Aura Biosciences to Participate in Upcoming Investor Conferences
01/05/2025
BOSTON, May 01, 2025 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today announced [...]
Alignment Healthcare Reports Strong First Quarter 2025 Results; Exceeds High-End of Expectations On 4 Critical KPIs; Raises Midpoint of 2025 Guidance; Announces CFO Transition
01/05/2025
Delivers Q1 revenue of $926.9 million, up 47.5% year over year, and grows Medicare Advantage (MA) membership by 31.7% to approximately 217,500 members Exceeds high-end of Q1 guidance on membership, revenue, adjusted [...]
Ascendis Pharma Reports First Quarter 2025 Financial Results
01/05/2025
- Q1 2025 revenue of €44.7 million for YORVIPATH ® and €51.3 million for SKYTROFA ® - TransCon ™ CNP NDA submitted in Q1 2025; MAA submission planned in Q3 2025 - Topline COACH combination trial ( TransCon CNP + [...]
scPharmaceuticals Announces Participation in Three Upcoming Investor Conferences
01/05/2025
BURLINGTON, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH) (the “Company”), a pharmaceutical company committed to revolutionizing cardiorenal healthcare through patient-centric innovations [...]
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/05/2025
CHARLESTOWN, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today [...]
Dyadic to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025
01/05/2025
JUPITER, Fla., May 01, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI), a biotechnology company focused on the efficient large-scale manufacture of [...]
Biofrontera and Almirall Launch the Hats On Challenge to Raise Awareness and Support for Actinic Keratosis
01/05/2025
The initiative is a social media challenge ahead of Global AK Awareness Day, on May 24, which supports the work of The Skin Cancer Foundation and Euromelanoma The Hats On Challenge provides an opportunity to take part [...]
Eascra Biotech Expands Operations with a New Worcester Lab
01/05/2025
Nanomedicine startup to conduct research and testing in the MBI facility BOSTON, May 01, 2025 (GLOBE NEWSWIRE) -- Eascra Biotech announced their first commercial lab, a preclinical startup space within the Massachusetts [...]
Best SARMs 2025: Strongest SARMs for Bulking, Cutting, Muscle Growth and Strength: Are SARMs Legal Or Safe? Best Sarm for Fat Loss - CrazyBulk
01/05/2025
Best SARMs For Bulking, Cutting, Strength & Muscle Growth Using SARMs to build strength and muscles is a common strategy, but are SARMs for strength and muscle development actually the best option for you? In this [...]
Comprehensive Healthcare Announces Grand Opening of Second Permanent Supportive Housing Facility to Serve the Lower Yakima Valley
01/05/2025
YAKIMA, Wash., May 01, 2025 (GLOBE NEWSWIRE) -- Comprehensive Healthcare today announced the expansion of its permanent supportive housing program in Sunnyside with the opening of Vista Del Sol-2 (VDS-2), a 20-unit long [...]

Pages